MLAB Stock Analysis: Buy, Sell, or Hold?
MLAB - Mesa Laboratories Inc
$95.61
0.22 (0.23%)
▲
5d:
-9.41%
30d:
-12.31%
90d:
+2.99%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Get Alerted When MLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MLAB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MLAB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$45.46
Based on -11.4% avg growth
INTRINSIC VALUE TODAY
$28.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MLAB is currently trading at $95.61, which is considered slightly low relative to its 30-day fair value range of $94.99 to $106.18. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.7) compared to its historical average (16.0). At these levels, the market is pricing in 3.4% annual earnings growth.
Technical Outlook: Technically, MLAB is in a strong uptrend. Immediate support is located at $81.30, while resistance sits at $113.99.
Market Sentiment: MLAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $112.00 (+17.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MLAB is in a strong uptrend. Immediate support is located at $81.30, while resistance sits at $113.99.
Market Sentiment: MLAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $112.00 (+17.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$94.99 -
$106.18
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($112.00)
- BULLISH: Expecting earnings turnaround to 3.4% growth with 2.6% revenue growth
- CAUTION: 5-day price weakness (-9.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$94.99 -
$106.18
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$81.30
Resistance Level
$113.99
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.74
Wall Street Target
$112.00
(+17.1%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
-28.7%
Profit Margin
2.7%
Valuation Premium vs History
+3.4% premium
PE vs Historical
17.7 vs 16.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$98.86
(+3%)
2-Year Target
$102.22
(+7%)
3-Year Target
$105.70
(+11%)
3-Yr Target (if PE normalizes)
(PE: 18→16)
PE COMPRESSION
$95.34
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -26.7%)
$85.58
(+-11%)
Base:
(SPY PE: 17.7, Growth: -26.7%)
$69.70
(-27%)
Bear:
(PE: 15.1, Growth: -26.7%)
$59.24
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Forward PE: 35.21 | Forward EPS (Implied): $2.72
Bull Case
$115.45
(+21%)
Analyst growth 15.0%, PE expands to 37.0
Base Case
$95.61
(0%)
Market implied 0.0%, PE stable at 35.2
Bear Case
$73.14
(-24%)
Severe decline -15.0%, PE contracts to 31.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 4:59 AM ET
Data refreshes hourly during market hours. Next update: 5:59 AM
Data refreshes hourly during market hours. Next update: 5:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLAB showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mark Christopher Capone
BUY
1301 shares
2026-03-10
R Tony Tripeny
BUY
1315 shares
2026-03-10
Shiraz Shabanali Ladiwala
BUY
3500 shares
2026-03-10
Top Rated Scientific & Technical Instruments Stocks
Top-rated stocks in Scientific & Technical Instruments by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CGNX
Cognex Corporation |
STRONG BUY
21 analysts |
$77 | 58 HOLD |
|
COHR
Coherent Inc |
STRONG BUY
19 analysts |
$387 | 48 HOLD |
|
TRMB
Trimble Inc |
STRONG BUY
12 analysts |
$84 | 63 BUY |
|
TDY
Teledyne Technologies In… |
STRONG BUY
13 analysts |
$737 | 66 BUY |
|
ITRI
Itron Inc |
STRONG BUY
13 analysts |
$127 | 62 BUY |
